CS logo
small CS logo
Clinical Neuroscience Solutions, Inc.

Orlando, Florida, United States
Corporate office
6750 Turkey Lake Rd, Orlando, FL 32819

About Clinical Neuroscience Solutions, Inc.


"Site Support Office"
  • Top Sponsors
  • Top Collaborators
  • Trials By Phase
  • Recruitment Status
  • Top Conditions
  • Intervention Types
  • Top Intervention Names
  • Trials By Gender
Lead Sponsor
# Trials

Clinical Trials at Clinical Neuroscience Solutions, Inc.


During the past decade, Clinical Neuroscience Solutions, Inc. conducted 104 clinical trials. In the 10-year time frame, 104 clinical trials started and 91 clinical trials were completed, i.e. on average, 87.5% percent of trials that started reached the finish line to date. In the past 5 years, 32 clinical trials started and 53 clinical trials were completed. i.e. 165.6% of trials that started reached the finish line.
Created with Highcharts 11.1.0TrialsTrials Trend - Last 10 Years171712121111171715151414141444778844441515171712121919Started TrialsCompleted Trails2015201620172018201920202021202201020
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Experimental Medication For the Treatment of Generalized Anxiety Disorder
2004-11-01
2005-12-01
Completed
511
18-Month Study of the Efficacy of Xaliproden (SR57746A) in Patients With Mild-to-Moderate Dementia of the Alzheimer's Type
2003-11-01
2007-10-01
Completed
1,306
Comparison of Escitalopram Combination in Adult Patients With Major Depressive Disorder
2005-03-01
2006-05-01
Completed
540
Study of BMS-562086 in the Treatment of Outpatients With Major Depressive Disorder
2005-11-01
2007-10-01
Completed
271
A 10-Week Efficacy and Safety Study of Gabitril in the Treatment of Adults With Generalized Anxiety Disorder
2004-11-01
2006-03-01
Completed
880
A Study of Aripiprazole (Abilify) in Patients With Bipolar Mania
2005-09-01
2009-10-01
Completed
1,270
Dose-Finding Study to Evaluate the Efficacy and Safety of Modafinil as Treatment for Adults With ADHD
2006-05-01
2007-01-01
Completed
370
Study to Assess the Safety and Efficacy of NRP104 in Adults With Attention-Deficit Hyperactivity Disorder (ADHD)
2006-05-01
2006-11-01
Completed
420

Rows per page:

1–100 of 172

Clinical Trials Sponsors and Collaborators


Out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 sponsor was "Shire" with 27 trials, followed by "Pfizer" with 26 trials sponsored, "Sunovion" with 16 trials sponsored, "Allergan" with 8 trials sponsored and "Eli Lilly and Company" with 8 trials sponsored. Other sponsors include 82 different institutions and companies that sponsored additional 54 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Clinical Neuroscience Solutions, Inc." #1 collaborator was "Pfizer" with 4 trials as a collaborator, "Purdue Pharma LP" with 2 trials as a collaborator, "Veristat, Inc." with 2 trials as a collaborator, "CoLucid Pharmaceuticals" with 1 trials as a collaborator and "GlaxoSmithKline" with 1 trials as a collaborator. Other collaborators include 6 different institutions and companies that were collaborators in the rest 16 trials.
Created with Highcharts 11.1.0Top Leading Sponsors

Created with Highcharts 11.1.0Top Collaborators

Clinical Trials Conditions at Clinical Neuroscience Solutions, Inc.


According to Clinical.Site data, the most researched conditions in "Clinical Neuroscience Solutions, Inc." are "Major Depressive Disorder" (21 trials), "ADHD" (9 trials), "Attention Deficit Hyperactivity Disorder (ADHD)" (9 trials), "Attention Deficit Hyperactivity Disorder" (8 trials) and "Binge Eating Disorder" (6 trials). Many other conditions were trialed in "Clinical Neuroscience Solutions, Inc." in a lesser frequency.

Clinical Trials Intervention Types at Clinical Neuroscience Solutions, Inc.


Most popular intervention types in "Clinical Neuroscience Solutions, Inc." are "Drug" (156 trials), "Biological" (16 trials), "Other" (16 trials), "Combination Product" (1 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (89 trials), "Dasotraline" (6 trials), "placebo" (5 trials), "Atogepant" (4 trials) and "BNT162b2" (4 trials). Other intervention names were less common.

Clinical Trials Genders at Clinical Neuroscience Solutions, Inc.


The vast majority of trials in "Clinical Neuroscience Solutions, Inc." are 167 trials for "All" genders and 5 trials for "Female" genders.

Clinical Trials Status at Clinical Neuroscience Solutions, Inc.


Currently, there are NaN active trials in "Clinical Neuroscience Solutions, Inc.". undefined are not yet recruiting, 9 are recruiting, 11 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 136 completed trials in Clinical Neuroscience Solutions, Inc., 1 suspended trials, and 12 terminated clinical trials to date.
Out of the total trials that were conducted in Clinical Neuroscience Solutions, Inc., 3 "Phase 1" clinical trials were conducted, 55 "Phase 2" clinical trials and 109 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 14 trials, and there were also 1 trials that are defined as “Not Applicable".
Created with Highcharts 11.1.0Trials By Phase

Created with Highcharts 11.1.0Trials Status